Transcriptionally Active High-Risk Human Papillomavirus is Not a Common Etiologic Agent in the Malignant Transformation of Inverted Schneiderian Papillomas

Abstract

The role of human papillomavirus (HPV) as an etiologic and transformational agent in inverted Schneiderian papilloma (ISP) is unclear. Indeed, reported detection rates of HPV in ISPs range from 0 to 100%. The true incidence has been confounded by a tendency to conflate high- and low-risk HPV types and by the inability to discern biologically relevant from irrelevant HPV infections. The recent development of RNA in situ hybridization for high-risk HPV E6/E7 mRNA now allows the direct visualization of transcriptionally active high-risk HPV in ISP, providing an opportunity to more definitively assess its role in the development and progression of ISPs. We performed p16 immunohistochemistry and high-risk HPV RNA in situ hybridization on 30 benign ISPs, 7 ISPs with dysplasia, 16 ISPs with carcinomatous transformation, and 7 non-keratinizing squamous cell carcinomas (SCCs) with inverted growth that were unassociated with ISP. Transcriptionally active HPV was not detected in any of the 52 ISPs including those that had undergone carcinomatous transformation, but it was detected in two of seven (29%) non-keratinizing SCCs that showed inverted growth. There was a strong correlation between high-risk HPV RNA in situ hybridization and p16 immunohistochemistry (97%; p < 0.01). These results indicate that transcriptionally active high-risk HPV does not play a common role in either the development of ISP or in its transformation into carcinoma.

Introduction

Inverted Schneiderian papillomas (ISPs) are uncommon neoplasms that comprise 0.5 to 4.0% of all sinonasal tumors [1–3]. While ISPs are fundamentally benign, they can demonstrate locally destructive growth, and they have a high rate of local recurrence [4–6]. Moreover, 5–15% of ISPs undergo malignant transformation into squamous cell carcinoma (SCC) and, less commonly, other carcinoma types such as mucoepidermoid carcinoma [7–9]. In cases with associated malignancy, the precise relationship of ISP to SCC is unclear. Although studies have confirmed the neoplastic (rather than reactive) nature of ISPs, these lesions do not fit the profile of the prototypic precursor lesion of head and neck SCC. ISPs are known to be clonal cellular proliferations, but they do not harbor the key genetic alterations that occur commonly and early during the initiation and progression of head and neck SCC [10]. A recent study identified identical EGFR mutations in a large proportion of ISPs and associated SCCs, strongly supporting a common origin for both tumor components and further underscoring a biology that is distinct from conventional SCCs of the head and neck where EGFR mutations are uncommon [11]. However, the factors that drive malignant transformation within this pathway have not yet been fully elucidated.

The notable absence of conventional genetic alterations in ISPs has suggested the possibility of high-risk human papillomavirus (HPV) as an alternative driver of malignant transformation. To date, however, the role of HPV in carcinomatous transformation of ISP is unresolved. Reported detection rates of HPV in ISPs have ranged from 0 to 100% [1, 3, 4, 7, 10, 12–34]. As for its role in biological progression, some studies have implicated HPV as a driving force behind tumor recurrence and carcinomatous transformation [9, 17, 22, 29, 34] while others have not [20, 28, 33]. The exasperating inability to discern the true role of HPV in ISP tumorigenesis largely reflects flaws in study design. First, some historical studies have overstated the role of HPV in carcinomatous transformation of ISPs by wholesale HPV testing without discriminating between low-risk and high-risk types [22, 35]. Second, many historical studies have employed assays that have not been able to couple the presence of HPV with evidence of its biologic activity, and thus have been unable to discern clinically relevant from irrelevant (e.g. viral contaminant or passenger virus) HPV infections [12]. The recent development of RNA in situ hybridization probes complementary to E6/E7 mRNA now permits direct visualization of viral transcripts in routinely processed tissues. In formalin-fixed and paraffin-embedded samples, RNA in situ hybridization permits direct visualization of transcriptionally active HPV RNA with a sensitivity and specificity that exceeds other methods of HPV detection [36–42]. Using a high-risk RNA ISH approach, we analyzed a series of ISPs along a morphologic and biologic continuum culminating in squamous cell carcinoma-ex ISP to elucidate the role of high-risk HPV in the process of carcinomatous transformation.

Materials and Methods

Case Selection

Study approval was obtained from the Johns Hopkins Medical Institutions Internal Review Board. Specimens were retrieved from the surgical pathology archives at the Johns Hopkins Hospital and included all consecutive cases of benign ISPs diagnosed from 2014 to 2015, all consecutive cases of ISPs with dysplasia diagnosed from 1999 to 2016, all consecutive cases of SCC arising from an ISP diagnosed from 1999 to 2016, and all consecutive cases of non-keratinizing SCCs that demonstrated a prominent inverted growth pattern diagnosed from 1999 to 2016. Pertinent clinical and demographic information was obtained from The Johns Hopkins Hospital’s electronic medical records. The histologic slides were reviewed and the diagnosis was confirmed for all cases.

Histologically, ISPs were defined by the presence of thickened epithelium with inverted growth and variable amounts of squamous, columnar, and mucinous cells (Fig. 1). All cases demonstrated intraepithelial neutrophils with scattered intraepithelial microabscesses. Cases diagnosed as dysplasia and SCC ex-ISP demonstrated clearly identifiable areas of pure benign ISP, but also showed areas with increased nuclear pleomorphism, high nuclear-cytoplasmic ratios, cellular dyspolarity, numerous apoptotic bodies, and prominent mitoses (Fig. 2a). In the cases of SCC ex-ISP, the atypia was full-thickness and more severe (Fig. 2b). The presence of overt stromal invasion was taken as definite evidence of carcinomatous transformation. The diagnosis of SCC ex-ISP required histologic or clinical documentation of a synchronous or metachronous ISP. For the non-keratinizing sinonasal SCCs, the tumors infiltrated the stroma as lobules of tumor cells with smooth rounded boarders simulating inverted growth (Fig. 3). Unlike conventional SCC, these carcinomas were characterized by the absence of keratinization and the lack of irregular stromal infiltration by angulated cords and nests of tumor cells. The non-keratinizing sinonasal SCCs were not associated with a synchronous or metachronous ISP.

Fig. 1.

Benign ISP is architecturally characterized by thickened surface epithelium showing deep downward growth as inverted rounded lobules (a). The epithelial cells are heavily permeated by neutrophils. Although the inverted nests are highly cellular with mitotic activity and loss of polarity, they lack significant cellular pleomorphism (b)

Fig. 2.

Inverted Schneiderian papilloma with carcinomatous progression. Benign inverted epithelium (a, left upper) shows abrupt transition with dysplastic epithelium characterized by nuclear hyperchromasia and loss of polarity (a, right lower). In other areas, the epithelium exhibits overtly malignant changes including necrosis, apoptosis and cellular atypia (b)

Fig. 3.

Non-keratinizing SCC of the sinonasal tract with inverted growth characterized by lobules of tumor cells with smooth and rounded borders (a). Despite some morphologic similarities to inverted Schneiderian papilloma, a synchronous or metachronous benign papilloma could not be histologically documented. Unlike the cases of Schneiderian papilloma with or without evidence of carcinomatous transformation, this carcinoma was positive for high-risk HPV (b) (high-risk HPV RNA in situ hybridization)

P16 Immunohistochemistry

P16 immunohistochemistry was performed using a mouse monoclonal antibody (MTM Laboratories, Heidelberg, Germany). Tumor sections were cut at five microns, deparaffinized, and subjected to antigen retrieval with 10 mM citrate buffer (92 °C for 30 min). Signals were visualized using the Ultra view polymer detection kit (Ventana Medical Systems, Tucson, AZ) and a Ventana BenchMark XT autostainer (Ventana). Staining was performed according to manufacturer’s instructions in the presence of appropriate controls. P16 interpretation was performed according to consensus standards established to correlate IHC reactivity with HPV status in oropharyngeal SCC [43], with only those cases that demonstrated diffuse staining, defined as strong nuclear and cytoplasmic positivity in >70% of tumor cells, considered positive for p16 overexpression.

HPV RNA In Situ Hybridization

RNA in situ hybridization for high-risk HPV E6/E7 mRNA was performed using the RNAscope HPV-HR18 Probe (Advanced Cell Diagnostics, Hayward, CA). Tumor sections were cut at five microns, pretreated with heat and protease, and hybridized with a single cocktail probe recognizing 18 high-risk HPV genotypes (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82). Preamplifier, amplifier and horseradish peroxidase-labeled probes were sequentially hybridized, and color was developed with diaminobenzidine. All steps were performed manually in the presence of appropriate controls. Cases processed using RNAScope were determined positive if they had punctate brown signals present in the cytoplasm and/or nucleus. Weak signals in tumor cells that could only be detected at ×20–40 magnification were not regarded as positive if the number and intensity of signal were not clearly above background [42].

Results

Fifty-nine tumors were evaluated from 51 patients. These included 30 ISPs without dysplasia, 6 ISPs with dysplasia, 16 ISPs with a synchronous (n = 14) or metachronous (n = 2) SCC (i.e. SCC ex-ISP), and 7 non-keratinizing SCCs of the sinonasal tract with inverted growth. Relevant clinical and pathologic information is summarized in Table 1. The study population was comprised of 31 males (61%) and 20 females (39%) with a mean age of 62 years (median 63, range 28–94). Tumors were centered in the nasal cavity (n = 22), maxillary sinus (n = 16), frontal sinus (n = 11), ethmoid sinus (n = 6), and sphenoid sinus (n = 4). Thirty-three tumors (56%) were primary lesions, and 26 (44%) were recurrent. Paired primary and recurrent tumors were both evaluated for five patients with recurrent ISPs and one patient with recurrent SCC ex-ISP.

Table 1.

Clinical and demographic information

Patient	Age	Sex	Location	Diagnosis	p16 IHC	HPV RNA ISH
1	70	M	Maxillary sinus	ISP	–	–
2	73	M	Maxillary sinus	ISP	–	–
3	74	F	Maxillary sinus	ISP	–	–
			Nasal cavity	ISP	–	–
4	51	F	Nasal cavity	ISP	–	–
			Nasal cavity	ISP	–	–
5	71	M	Frontal sinus	ISP	–	–
			Frontal sinus	ISP	–	–
			Frontal sinus	ISP	–	–
6	63	M	Ethmoid sinus	ISP	–	–
7	54	M	Ethmoid sinus	ISP	–	–
8	48	M	Frontal sinus	ISP	–	–
			Frontal sinus	ISP	–	–
			Frontal sinus	ISP	–	–
9	54	F	Frontal sinus	ISP	–	–
10	94	M	Nasal cavity	ISP	–	–
11	39	F	Maxillary sinus	ISP	–	–
12	64	M	Frontal sinus	ISP	–	–
13	75	M	Nasal cavity	ISP	–	–
			Maxillary sinus	ISP	–	–
14	55	M	Nasal cavity	ISP	–	–
15	45	F	Nasal cavity	ISP	–	–
16	57	M	Nasal cavity	ISP	–	–
17	68	M	Maxillary sinus	ISP	–	–
18	28	M	Nasal cavity	ISP	–	–
19	61	F	Sphenoid sinus	ISP	–	–
20	53	F	Maxillary sinus	ISP	–	–
21	58	M	Nasal cavity	ISP	–	–
22	75	M	Ethmoid sinus	ISP	–	–
23	56	M	Maxillary sinus	ISP	–	–
24	81	M	Nasal cavity	ISP with dysplasia	–	–
25	70	M	Frontal sinus	ISP with dysplasia	–	–
26	64	F	Nasal cavity	ISP with dysplasia	–	–
27	63	M	Frontal sinus	ISP with dysplasia	–	–
28	53	F	Sphenoid sinus	ISP with dysplasia	–	–
29	79	F	Nasal cavity	ISP with dysplasia	–	–
30	55	F	Maxillary sinus	SqCC ex ISP	–	–
			Nasal cavity	SqCC ex ISP	–	–
31	86	F	Nasal cavity	SqCC ex ISP	–	–
32	51	M	Nasal cavity	SqCC ex ISP	–	–
33	77	M	Maxillary sinus	SqCC ex ISP	–	–
34	49	M	Nasal cavity	SqCC ex ISP	–	–
35	46	F	Ethmoid sinus	SqCC ex ISP	+	–
36	51	F	Frontal sinus	SqCC ex ISP	–	–
37	58	M	Nasal cavity	SqCC ex ISP	–	–
38	62	M	Maxillary sinus	SqCC ex ISP	–	–
39	61	F	Maxillary sinus	SqCC ex ISP	–	–
40	75	M	Maxillary sinus	SqCC ex ISP	–	–
41	87	F	Maxillary sinus	SqCC ex ISP	–	–
42	74	M	Maxillary sinus	SqCC ex ISP	–	–
43	63	F	Ethmoid sinus	SqCC ex ISP	–	–
44	58	F	Sphenoid sinus	SqCC ex ISP	–	–
45	70	M	Maxillary sinus	NKSqCC, inverted	–	–
46	47	F	Frontal sinus	NKSqCC, inverted	+	–
47	63	F	Nasal cavity	NKSqCC, inverted	+	+
48	63	M	Nasal cavity	NKSqCC, inverted	-	–
49	71	M	Nasal cavity	NKSqCC, inverted	–	–
50	81	M	Nasal cavity	NKSqCC, inverted	+	+
51	37	M	Sphenoid sinus	NKSqCC, inverted	–	–

IHC Immunohistochemistry, ISH In situ hybridization for high-risk HPV types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82; M male, F female, ISP inverted Schneiderian papilloma, SqCC squamous cell carcinoma, NKSqCC non-keratinizing squamous cell carcinoma

Patchy p16 by immunohistochemistry was noted in 25 of 30 (83%) of the ISPs without dysplasia and in 2 of 6 (33%) ISPs with dysplasia; but staining was well below the 70% threshold that is generally considered consistent with high-risk HPV infection [44]. As such, all 30 ISPs without dysplasia and all 6 ISPs with dysplasia were p16 negative. Positive p16 staining was present in only 1 of 16 (6%) of SCC ex-ISPs. In contrast, diffuse p16 positivity was present in 3 of 7 (43%) of the invasive non-keratinizing SCCs. High-risk HPV RISH did not detect the presence of transcriptionally active HPV in any of the ISPs including those without dysplasia (0 of 30, 0%), those with dysplasia (0 of 6, 0%), and those that harbored SCC (carcinoma-ex-ISPs) (0 of 16, 0%). High-risk HPV RISH was detected in 2 of 7 (29%) non-keratinizing SCCs with inverted growth.

Although this analysis is limited by the small number of HPV-positive tumors included in this study, there was a 96% correlation rate overall between HPV status and p16 immunohistochemical staining. All 55 (100%) of the p16 negative tumors were HPV negative by RNA in situ hybridization, and 2 of the 4 (50%) p16 positive tumors were HPV positive by RNA in situ hybridization. Using detection of viral mRNA transcripts as definite evidence of a relevant high-risk HPV infection, p16 overexpression as measured by p16 immunohistochemistry had a positive predictive value of 0.5 (0.09–0.91, 95% CI) and a negative predictive value of 1 (0.09–0.91, 95% CI).

Discussion

The molecular genetic changes driving malignant transformation of an ISP are not well understood, but the finding that approximately one-third of non-keratinizing SCCs of the sinonasal tract harbor high-risk HPV suggests that this oncovirus may be an important etiologic agent. Numerous studies to confirm the importance of HPV in this process, however, have only obscured the role of HPV in the formation, recurrence and malignant transformation of ISPs. Reported detection rates of HPV in ISPs and those that have undergone carcinomatous transformation have ranged from 0 to 100% [1, 3, 4, 7, 10, 12–34]. Much of this ambiguity reflects suboptimal detection methodologies including the inability to discern biologically relevant from irrelevant HPV.

Taking advantage of recently developed RNA in-situ hybridization probes complementary to E6/E7 mRNA that now permit direct visualization of viral transcripts in routinely processed tissues, we were able to confirm that transcriptionally active HPV is seldom encountered in ISPs or in those ISPs showing evidence of carcinomatous transformation. Indeed, E6/E7 mRNA viral transcripts were not detected in any of the benign ISPs, ISPs with dysplasia, or carcinomas ex-ISP. Using a similar RNA in situ hybridization strategy, Nudell et al. [9] detected transcriptionally active high-risk HPV in 3 of 17 (18%) carcinomas ex-ISPs. These results do not statistically depart from our own (p = 0.23, Fischer 2-tailed test) and further underscore the point that while HPV may be associated with carcinoma ex-ISPs, its presence is neither invariable nor common. Carcinomatous transformation of ISPs is driven by non-HPV mechanisms for most ISPs.

“Schneiderian carcinoma” is a bygone designation that was historically applied to non-keratinizing SCC of the sinonasal tract [45]. Reminiscent of Schneiderian papillomas, these carcinomas characteristically invade in an inverted fashion as rounded ribbons and lobules of tumor cells (Fig. 3). They tend to lack the overt keratinization and irregular invasive growth that characterize most conventional head and neck SCCs. Indeed, the second series of the AFIP Tumors of the upper respiratory tract and ear drew early attention to the way these carcinomas are easily mistaken for inverted Schneiderian papilloma [46]. This morphologic parallel has fostered a persistent notion that many of these “Schneiderian carcinomas” (i.e. non-keratinizing sinonasal SCCs with inverted growth) represent the malignant counterpart of ISPs. We detected transcriptionally active HPV in 27% of these non-keratinizing SCCs. This rate of HPV detection is comparable to other studies where HPV has been detected in about one-third of non-keratinizing SCCs of the sinonasal tract [21, 47]. The observation that transcriptionally active HPV is present in some non-keratinizing sinonasal SCCs with inverted growth but not in ISPs showing dysplastic changes or overt carcinoma (2 of 7 vs. 0 of 22, p = 0.052) underscores the absence of an etiologic link between the two lesions. When encountering SCC of the sinonasal tract characterized by an inverted pattern of growth, the assumption that the tumor arose from a pre-existing ISP (in the absence of a benign component) may not be correct.

ISPs are benign, but local recurrence and even malignant transformation is a constant hazard. Efforts to predict those ISPs that are likely to recur or undergo malignant transformation on the basis of microscopic features or even molecular genetic alterations have not been successful [10]. Our study suggests that HPV detection as a strategy to assess risk of aggressive tumor behavior would not be effective. Benign ISPs do not appear to harbor transcriptionally active high-risk HPV. Moreover, in those ISPs that already show morphologic evidence of carcinomatous transformation, the role of HPV in this process is not vital in most cases. Transcriptionally active HPV may be present in some fully malignant non-keratinizing SCCs of the sinonasal tract with inverted growth, but these carcinomas may arise independently of ISP.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.